C-reactive protein, lung hyperinflation and heart rate variability in chronic obstructive pulmonary disease - A pilot study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 2, 2013, Pages 200-207

  Corbo, Giuseppe Maria ^a   Inchingolo, Riccardo ^a   Sgueglia, Gregory Angelo ^a   Lanza, Gaetano ^a   Valente, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autonomic function; Chronic obstructive pulmonary disease; Inflammation; Six minute Walk Test.

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; MALE; PILOT STUDY; PRIORITY JOURNAL; PULSE OXIMETRY; REST;

AGED; C-REACTIVE PROTEIN; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; INSPIRATORY CAPACITY; LUNG; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REST; SEVERITY OF ILLNESS INDEX;

EID: 84875909650     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.710667     Document Type: Article

References (36)

1. Sin DD, Man SFP. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8-11.
2. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348:567-72.
3. Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914", Malmö, Sweden. Circulation 2001; 103: 3086-91.
4. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-9.
5. Ferguson GT, Calverley PMA, Anderson JA, et al. Incidence of cardiac events in COPD patients in the TORCH study. Am J Respir Crit Care Med 2008; 177:A962.
6. Vestbo J. Torch Study Group. The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J 2004; 24:206e10.
7. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62(5):411-5.
8. Casanova C, Cote C, de Torres JP et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):591-7.
9. Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation. Am J Med Sci 2010; 339(5):411-4.
10. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(3):250-5.
11. Sin DD, Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 2007; 85(1):141-7.
12. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989; 64:1162-7.
13. Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10(1):88-101.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17(3):354-81.
15. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106(5):1432-7.
16. Stein PK, Nelson P, Rottman JN, et al. Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. Chest 1998; 113(2):327-33.
17. Takabatake N, Nakamura H, Minamihaba O, et al. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med 2001; 163(6):1314-9.
18. Bartels MN, Jelic S, Ngai P, Basner RC, DeMeersman RE. High-frequency modulation of heart rate variability during exercise in patients with COPD. Chest 2003; 124(3):863-9.
19. Miller MR, Crapo R, Hankinson J, et al. ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005; 26(1):153-61.
20. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 526(2):319-38.
21. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511-22
22. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4):720-35.
23. Camillo CA, Pitta F, Possani HV, et al. Heart rate variability and disease characteristics in patients with COPD. Lung 2008; 186(6):393-401.
24. Antonelli Incalzi R, Corsonello A, Trojano L, et al. Heart rate variability and drawing impairment in hypoxemic COPD. Brain Cogn 2009; 70(1):163-70.
25. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-62.
26. März P, Cheng JG, Gadient RA, et al. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998; 95:3251-6.
27. Banks WA, Kastin AJ. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 1991; 48:PL117-21.
28. Undem BJ, Kollarik M. The role of vagal aff erent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(4):355- 360;discussion371-2.
29. Lanza GA, Sgueglia GA, Cianflone D, et al., SPAI (Stratificazione Prognostica dell'Angina Instabile) Investigators. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol Jun 2006; 15;97(12):1702-6.
30. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12:294-300.
31. Lampert R, Bremner JD, Su S, et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156(4):759.e1-759.e7.
32. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 2006; 260(4):377-87.
33. Martinez FJ, Foster G, Curtis JL, et al., NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173(12):1326-34.
34. Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138(1):32-8.
35. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128(4):2025-34.
36. Camillo CA, Laburu Vde M, Gonçalves NS, et al. Improvement of heart rate variability after exercise training and its predictors in COPD. Respir Med 2011; 105(7):1054-62.